![Pat O’Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Pat O’Sullivan worked at Genzyme Therapeutics Ltd. from 2001 to 2022 as Vice President-Global Supply Chain.
From 2022 to 2026, Mr. O’Sullivan worked at Amicus Therapeutics, Inc. as Chief Technical Operations Officer.
Mr. O’Sullivan completed an MBA at The Open University and an undergraduate degree at Munster Technological University.
Eerdere bekende functies van Pat O’Sullivan
| Bedrijven | Functie | Einde |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Operationeel Directeur | 27-04-2026 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | 01-08-2022 |
Opleiding van Pat O’Sullivan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
28
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Munster Technological University
 Munster Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
